Z世代はアトピー性皮膚炎の重症度をより重く認識
Z世代の患者はミレニアル世代の患者と比べてアトピー性皮膚炎をより深刻に捉える
グラナダ大学（スペイン）のClara Ureña-Paniego氏らは、Z世代（1993～2001年生まれ）とミレニアル世代（1978～1992年生まれ）の患者間で、アトピー性皮膚炎の臨床的な重症度と主観的な影響を比較した。解析には、中等度～重度のアトピー性皮膚炎患者73人が含まれた。
解析の結果、Z世代の患者はミレニアル世代の患者と比較して、アトピー性皮膚炎の重症度が低かった（湿疹⾯積重症度指数〔EASI〕9.75対16.63）。しかし、病気の重症度に対する認識に関しては、両世代で類似していた（アトピー性皮膚炎重症度評価法〔SCORAD〕43.54対32.98、患者志向湿疹評価尺度〔POEM〕13.21対15.48）。
著者らは、「Z世代はミレニアル世代よりも主観的な重症度を重く認識している。この世代間の違いを理解することは、より効果的な治療戦略の作成に役立ち、各世代特有のニーズと期待に応じた治療方針を提供するために重要である。この方針には、治療のリスクと期待についての患者教育の強化、治療調整の適時実施のための定期的な追跡診察、ストレス管理や保湿剤の使用などの非薬理学的療法の導入、そしてメンタルヘルス専門家の治療チームへの参加が含まれる」と述べている。
International Journal of Dermatology
Gen Z Perceives Atopic Dermatitis to Be More Severe
Perceived severity higher among Gen Z compared with millennial patients
TUESDAY, July 30, 2024 (HealthDay News) -- Generation Z (Gen Z) patients present with a higher subjective perception of atopic dermatitis severity than millennial generation patients, according to a study published online July 25 in the International Journal of Dermatology.
Clara Ureña-Paniego, from the University of Granada in Spain, and colleagues compared the clinical severity and subjective impact of atopic dermatitis between Gen Z patients (born between 1993 and 2001) and millennials (born between 1978 and 1992). The analysis included 73 patients with moderate-to-severe atopic dermatitis.
The researchers found that patients belonging to Gen Z exhibited a lower severity of atopic dermatitis versus millennials (Eczema Area and Severity Index: 9.75 versus 16.63). However, the two generations were similar with respect to their perception of disease severity (SCORing Atopic Dermatitis: 43.54 versus 32.98; Patient-Oriented Eczema Measure: 13.21 versus 15.48).
"Gen Z presents a higher subjective perception of severity than millennials. Understanding these generational disparities contributes to creating more effective treatment strategies and provides a more targeted approach to care that addresses each generational group's unique needs and expectations," the authors write. "This approach could include enhanced patient education on treatment risks and expectations, regular follow-up visits for timely treatment adjustment, integration of nonpharmacological therapies like stress management and use of emollients, and inclusion of mental health professionals in the care team."
International Journal of Dermatology